Rosuvastatin Calcium

This page contains recent news articles, when available, and an overview of Rosuvastatin Calcium but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Crestor Patent Invalidity Evidence Uncovered By Article One ...  -  ‎Jul 1, 2009‎
CRESTOR(R) (rosuvastatin calcium) is a prescription drug for treating high cholesterol. The discovery of this patent invalidity evidence can impact the PR Newswire (press release)

Abbott's dyslipidemia trial meets primary endpoints  -  ‎Apr 1, 2009‎
Trilipix 135mg in combination with rosuvastatin calcium 5mg significantly improved high-density lipoprotein (HDL) cholesterol and triglycerides compared to Pharmaceutical Business Review

Abbott Labs' Q1 - Healthy Or Sick?  -  ‎Apr 15, 2009‎
Abbott and British drug maker AstraZeneca plc (AZN) are working together to develop a fixed-dose combination of TriLipix and Crestor (rosuvastatin calcium). RTT News

매�?�경제 홈 > 뉴스센터 > �?�젣곗뾽  -  ‎Apr 2, 2009‎
ABOUT CRESTOR (ROSUVASTATIN CALCIUM): Studies have previously shown that CRESTOR significantly lowered LDL-C, atherosclerosis, an underlying cause of 매일경제

Market Report -- In Play ()  -  ‎Mar 30, 2009‎
Data from a new study showed that Abbott's (ABT) TRILIPIX delayed-release capsules in combination with rosuvastatin calcium met all of the study's primary MSN Money

Study Identifies Rosuvastatin’s Potential to Reduce Cardiovascular ...  -  Dec 4, 2008
Now, the administration of rosuvastatin calcium (CRESTOR® | AstraZeneca) into evidently healthy people with elevated hsCRP levels, MediNEWS.Direct!,

Science and Technology A new dimension to heart treatment  -  Dec 3, 2008
The results of the landmark trial showed that rosuvastatin calcium 20mg significantly reduced major cardiovascular events which was seen in men and women Philippine Star,

Drug and Therapeutics Update  -  Dec 21, 2008
Colistimethate sodium inhalation powder, and Etravirine for infectious diseases; Corifollitropin alfa and Rosuvastatin calcium for endocrinological, OnMedica,

Abbott Receives FDA Approval for TRILIPIX™ (fenofibric acid ...  -  Dec 17, 2008
...combination of Abbott’s TRILIPIX and AstraZeneca’s CRESTOR® (rosuvastatin calcium) with plans to submit a new drug application to the FDA in 2009. PR-USA.net (press release),

Science and Technology Results of landmark statin study revealed  -  Nov 19, 2008
The results of the landmark trial showed that rosuvastatin calcium 20 mg significantly reduced major cardiovascular events that include combined risk of Philippine Star,

Physicians Anticipate Higher Prescribing Based on JUPITER Study  -  Nov 21, 2008
The JUPITER study showed that CRESTOR (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events by 44% compared with placebo among MarketWatch

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin ...  -  Nov 9, 2008
NEW ORLEANS, Nov 09, 2008 /PRNewswire-FirstCall via COMTEX/ -- New data from the JUPITER study demonstrated that CRESTOR(R) (rosuvastatin calcium) 20 mg MarketWatch

CNW BROADCAST SERVICES  -  Nov 9, 2008
...of key findings, stats, graph, (rosuvastatin calcium) had reduced chart, etc. first cardiovascular events by 44% compared to a placebo. Canada NewsWire (press release),

Crestor zeigt dramatische KV-Risikoreduktion in einer grossen ...  -  Nov 10, 2008
Zug (ots) - Neue Daten der JUPITER Studie zeigen, dass CRESTOR® (Rosuvastatin-Calcium) 20 mg unter Männern und Frauen mit erhöhtem hsCRP (hochsensitivem news aktuell Schweiz (Pressemitteilung),

Abbott Reports Strong Sales and Earnings Growth in Third Quarter ...  -  Oct 15, 2008
AstraZeneca Relationship Expanded -- In August, announced an agreement with AstraZeneca to promote AstraZeneca's CRESTOR(R) (rosuvastatin calcium), MarketWatch

Court Report  -  Oct 12, 2008
2007) based on AstraZeneca's manufacture and sale of its Crestor® (rosuvastatin calcium, used to treat high cholesterol). View the complaint here. Patent Docs,

Abbott And AstraZeneca Expand Relationship To Include  -  Aug 17, 2008
Abbott and AstraZeneca announced recently that they have entered into an agreement for Abbott to promote AstraZeneca's CRESTOR (rosuvastatin calcium), Pharmaceutical Online (press release),

아보트/아스트�?�, ‘�?�레스토’ 공�?� �?촉 합�?�  -  Aug 19, 2008
...�?�레스토(rosuvastatin calcium)는 스타틴 계열�?� 항 콜레스테롤 약물로 �? 콜레스테롤 �? LDL-콜레스테롤 �?�?� 저하 목�?�? 사용�?�고 있다. 메디�?�뉴스,

Abbott's Phase III Sub-Group Analysis Shows Investigational ...  -  Jun 8, 2008
III study showed that the use of Abbott's investigational TriLipix(TM) (ABT-335) in combination with AstraZeneca's CRESTOR(R) (rosuvastatin calcium), FOXBusiness

ABT-335 improved lipid levels in patients with mixed dyslipidemia ...  -  Jun 9, 2008
Use of the investigational drug ABT-335 in combination with rosuvastatin calcium demonstrated similar improvements in LDL, HDL and triglycerides, Endocrine Today,

Abbott's Phase III Sub-Group Analysis Shows Investigational ...  -  Jun 7, 2008
III study showed that the use of Abbott's investigationalTriLipix(TM) (ABT-335) in combination with AstraZeneca's CRESTOR(R)(rosuvastatin calcium), istockAnalyst.com,

Toward "Pain-Free" Statin Prescribing: Clinical Algorithm for ...  -  Jun 14, 2008
Crestor (rosuvastatin calcium) [package insert]. Wilmington, DE: AstraZeneca; 2007. http://wwwl.astrazeneca-us.com/pi/ crestor.pdf. Accessed April 11, 2008. RedOrbit,

Phase III Study of Abbott's Investigational TriLipix(TM) in ...  -  May 31, 2008
Abbott's investigational TriLipix(TM) (ABT-335) combined with AstraZeneca's CRESTOR(R) (rosuvastatin calcium) led to greater improvements than the Earthtimes (press release),

Astrazeneca Stops Cholesterol Drug Trial Because Of Promising Results  -  Apr 1, 2008
Crestor (rosuvastatin calcium) because early findings showed that the drug reduced deaths and risk of heart problems in patients compared to placebo. Medical News Today,

AstraZeneca Halts Crestor Trial After Early Success  -  Apr 7, 2008
...board and steering committee recently met and recommended the clinical trial be stopped early due to Crestor’s (rosuvastatin calcium) success. FDA news (subscription),

AstraZeneca Halts Crestor Trial After Early Success  -  Apr 1, 2008
...data monitoring board and steering committee recommended the clinical trial be stopped early due to Crestor’s (rosuvastatin calcium) success. FDA news (subscription),

Schering-Plough: Lower Is Better Remains in Effect  -  Feb 19, 2008
Vytorin is marketed as lowering LDL cholesterol levels more than Lipitor or AstraZeneca’s Crestor (rosuvastatin calcium) alone. FDA news (subscription),

Advisory Committee Rejects OTC Mevcaor  -  20 Dec 2007
...on more potent statins, such as Pfizer’s Lipitor (atorvastatin calcium) and AstraZeneca’s Crestor (rosuvastatin calcium), would switch to OTC Mevacor. FDA news (subscription),

AstraZeneca Files Patent Infringement Actions in Response to ...  -  Dec 12, 2007
Teva did not notify AstraZeneca that they intended to market generic rosuvastatin calcium tablets prior to the expiration of the ‘314 patent, which covers PharmaLive.com (press release),

Pharmaceutical patent round-up  -  Dec 13, 2007
...which have submitted Abbreviated New Drug Applications (ANDA) for Crestor (rosuvastatin calcium), a cholesterol drug. Filed in the US District Court, In-PharmaTechnologist.com,

Bunzl Says FY07 Overall Trading In Line With Expectations [BNZL.L]  -  Dec 12, 2007
Crestor or rosuvastatin calcium is a prescription drug belonging to a group of medicines called statins that is used for treating high cholesterol. RTT News,

New Analysis of METEOR Study Demonstrate Effects of astrazeneca's ...  -  Nov 7, 2007
...(Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin) showed CRESTOR(R) (rosuvastatin calcium) 40 mg slowed the progression of CNNMoney.com

CRESTOR(R) Now Indicated to Slow the Progression of ...  -  Nov 9, 2007
9 /prnewswire-firstcall/ -- astrazeneca announced today that the US Food and Drug Administration (FDA) has approved CRESTOR(R) (rosuvastatin calcium) as an CNNMoney.com

Astrazeneca's Crestor gets FDA approval for atherosclerosis  -  Nov 9, 2007
...has approved Crestor, or rosuvastatin calcium, as an adjunct to diet, to slow the progression of atherosclerosis in patients with elevated cholesterol. MarketWatch

astrazeneca: Crestor® now indicated to slow the progressi...  -  Nov 8, 2007
...astrazeneca announced today that the US Food and Drug Administration(FDA) has approved CRESTOR® (rosuvastatin calcium) as an adjunct to dietto slow the Privata Affärer,

Statin: Regulators extend licence, even though it doesn’t help ...  -  Nov 15, 2007
On the very day when astrazeneca’s cholesterol-lowering statin drug Crestor (rosuvastatin calcium) was approved to treat atherosclerosis (hardening of the What Doctors Don't Tell You,

astrazeneca's Net Income Falls 15% On Restructuring, Acquisition Costs  -  Nov 1, 2007
...an abbreviated new drug application, or ANDA, to the US Food and Drug Administration for approval to market generic rosuvastatin calcium tablets. Wall Street Journal

New Data Examines the Effect of Adding a Statin to Optimized ...  -  Nov 5, 2007
Patients taking astrazeneca's CRESTOR(R) (rosuvastatin calcium) 10 mg experienced an 8 percent reduction in the combined primary endpoint of cardiovascular PR Newswire (press release),

astrazeneca is worst stock in its sector, say analysts  -  Nov 14, 2007
...the schizophrenia treatment Seroquel (quetiapine) and the cholesterol drug Crestor (rosuvastatin calcium) will become exposed to patent expiry up to Pharma Times (subscription),

astrazeneca in 'serious trouble', say analysts  -  Nov 14, 2007
The worst case assumes that generics hit Nexium (esomeprazole) and Seroquel (quetiapine) in 2008 and Crestor (rosuvastatin calcium) in 2009", the analysts In-PharmaTechnologist.com,

astrazeneca faces Crestor generic challenge  -  Nov 1, 2007
...astrazeneca has been issued a generic challenge to its blockbuster cholesterol drug Crestor (rosuvastatin calcium) by Canada's Cobalt pharmaceuticals. Medical Marketing and Media,

Cobalt seeking approval for rival Astra drug  -  Nov 1, 2007
Cobalt has submitted an Abbreviated New Drug Application (ANDA) to the US Food and Drug Administration for approval to market generic rosuvastatin calcium Healthcare Digital,

Generic rivals ratchet up pressure on Astra  -  Nov 1, 2007
...applied to the US Federal Drug Administration for permission to begin manufacturing a generic version of Crestor, a compound of rosuvastatin calcium. Independent,

astrazeneca Says Adding A Statin To Optimized Heart Failure ...  -  Nov 5, 2007
...the company said patients who took astrazeneca's Crestor or rosuvastatin calcium 10 mg experienced a statistically insignificant 8% reduction in the Trading Markets (press release),

Cytogen Q3 Net Loss Narrows - Quick Facts [CYTO]  -  Nov 5, 2007
The company noted that patients taking its CRESTOR, rosuvastatin calcium, 10 mg experienced an 8% reduction in the combined primary endpoint of RTT News,

Abbott and AstraZeneca Announce Selection of Next-Generation ...  -  Aug 31, 2007
CRESTOR (rosuvastatin calcium) is a once-daily, lipid-lowering agent prescription medication for use as an adjunct to diet in the treatment of various lipid PR Newswire (press release),

Abbott and AstraZeneca combine cholesterol drugs  -  Sep 5, 2007
The two companies will advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's Crestor (rosuvastatin calcium) in a OutSourcing-Pharma.com,

Abbott And AstraZeneca To Advance Trial Of Combo Cholesterol Pill ...  -  Aug 31, 2007
...fenofibrate ABT-335 and AstraZeneca's Crestor or rosuvastatin calcium in a fixed-dose combination treatment into Phase III clinical trials. RTT News,

AstraZeneca, Abbott to Advance ABT-335 and Crestor Fixed-Dose ...  -  Aug 31, 2007
Based on the progress made in the ABT-335 and Crestor (rosuvastatin calcium) fixed-dose combinations development program, the companies said they have FDA news (subscription),

The 340B Prime Vendor Program Adds AstraZeneca's Cholesterol ...  -  Aug 1, 2007
WM Experts (press release),International, LLC), announced today that the cholesterol-lowering statin Crestor® (rosuvastatin calcium) is now available to participants.

Mission: Catching counterfeiters. Impossible?  -  Jun 28, 2007
In-PharmaTechnologist.com,Hyzaar (losartan potassium-hydrochlorothiazide); Zetia (ezetimibe); Crestor (rosuvastatin calcium); Celebrex (celecoxib); Arimidex (anastrozole) and

New Clinical Trial Shows CRESTOR(R) Significantly Slowed ...  -  Mar 29, 2007
PR Newswire (press release),...double-blind, multi-national study comparing the effects of two years of treatment with CRESTOR(R) (rosuvastatin calcium) 40mg with placebo on carotid

Cheaper drugs good news for patients  -  Dec 2, 2006
Sydney Morning Herald,About 700000 people with high blood cholesterol levels will be treated over the next four years with rosuvastatin calcium (Crestor) at a cost of $9.1

www.crestor.com: CORONA and Heart Failure  Oct 31, 2006
The goal of the CORONA study is to determine the effect of CRESTOR® (rosuvastatin calcium) 10 mg on a combined endpoint of cardiovascular death, non-fatal ... -Market Wire (press release) Canadian Web Sites Selling Counterfeit Drug Products  Sep 1, 2006
...sodium), Nexium (esomeprazole), Hyzaar (losartan potassium/ hydrochlorothiazide), Zetia/Ezetrol (ezetimibe), Crestor (rosuvastatin calcium), Celebrex (celecoxib ... -Facts and Comparisons

AstraZeneca's Crestor overcomes safety concerns  Aug 27, 2006
While analysts don't expect Lipitor to relinquish its wide lead any time soon, Crestor, the chemical name of which is rosuvastatin calcium, has been steadily ... -The News Journal

AstraZeneca's Crestor overcomes safety concerns  Aug 27, 2006
While analysts don't expect Lipitor to relinquish its wide lead any time soon, Crestor, the chemical name of which is rosuvastatin calcium, has been steadily ... -The News Journal

Elan Reports Second Quarter 2006 Financial Results  Jul 31, 2006
...product containing the active pharmaceutical ingredients in Abbott's TriCor 145 (fenofibrate) and AstraZeneca's Crestor(R) (rosuvastatin calcium) products. ... -Business Wire

(ABT-335) Fixed-Dose Combination  Jul 19, 2006
Under the agreement, the companies will initiate two parallel programs: a CRESTOR® (rosuvastatin calcium)/TriCor® (fenofibrate tablets) fixed-dose ... -Pharmaceutical Processing

Abbott and AstraZeneca Announce Collaboration to Develop and ...  Jul 6, 2006
Under the agreement, the companies will initiate two parallel programs: a CRESTOR(R) (rosuvastatin calcium)/TriCor(R) (fenofibrate tablets) fixed-dose ... -Drug Newswire

Get the latest news direct to your desktop  Jul 6, 2006
...product containing the active pharmaceutical ingredients in Abbott's TriCor(R) 145 (fenofibrate) and AstraZeneca's Crestor(R) (rosuvastatin calcium) products. ... -PipelineReview.com

New Data Shows CRESTOR(R) Helped African American, Hispanic ...  Jun 23, 2006
...presented today at the International Symposium on Atherosclerosis (ISA) demonstrate that AstraZeneca's CRESTOR(R) (rosuvastatin calcium) effectively reduced ... -Medical News Today

Elan Signs License Agreement with Abbott for Elan's Proprietary ...  Jul 5, 2006
...product containing the activepharmaceutical ingredients in Abbott's TriCor(R) 145 (fenofibrate) andAstraZeneca's Crestor(R) (rosuvastatin calcium) products. ... -Finanzen.net

Abbott and AstraZeneca to Collaborate on First Statin/Fibrate ...  Jul 5, 2006
Two parallel programs will be initiated under the agreement: a Crestor(rosuvastatin calcium)/TriCor (fenofibrate) fixed-dose combination and a Crestor/ABT-335 ... -Facts and Comparisons

AstraZeneca Announces Pact With Abbott  Jul 5, 2006
...proprietary, next-generation fenofibrate (ABT-335) currently in Phase III clinical trials and AstraZeneca's marketed statin, CRESTOR (rosuvastatin calcium). ... -Easy Bourse (Communiqués de presse)

AstraZeneca And Abbott To Co-Develop And Co-Market A Single-Pill ...  Jul 6, 2006
...s proprietary, next-generation fenofibrate (ABT-335) currently in Phase III clinical trials and AstraZeneca’s marketed statin, CRESTOR® (rosuvastatin calcium ... -PharmaLive.com

Elan agrees US license of its proprietary NanoCrystal Technology  Jul 5, 2006
...product containing the active pharmaceutical ingredients in Abbott's TriCor 145 (fenofibrate) and AstraZeneca's Crestor (rosuvastatin calcium) products. ... -FinFacts Ireland

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com/health lead to other sites. health.mongabay.com/health does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com/health responsible for dead or misdirected links.

IF YOU NEED A LINK/TEXT REMOVED FROM THIS PAGE, PLEASE CONTACT: mongabay (at) gmail.com